Pregnant women with hepatitis c get new hope from antiviral drug
Disease control
Ongoing
This study is testing a 12-week course of the hepatitis C drug Sofosbuvir/Velpatasvir in about 100 pregnant women. The goal is to see if the treatment cures the infection and whether it affects the timing of delivery. Mothers are followed for 12 weeks after treatment, and babies …
Phase: PHASE4 • Sponsor: Catherine Anne Chappell • Aim: Disease control
Last updated May 12, 2026 13:43 UTC